Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Gains from Investment Securities: 2010-2024

Historic Gains from Investment Securities for Vericel (VCEL) over the last 14 years, with Dec 2024 value amounting to $5.5 million.

  • Vericel's Gains from Investment Securities rose 12.55% to $305,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 6.15%. This contributed to the annual value of $5.5 million for FY2024, which is 85.61% down from last year.
  • According to the latest figures from FY2024, Vericel's Gains from Investment Securities is $5.5 million, which was down 85.61% from $38.0 million recorded in FY2023.
  • Vericel's 5-year Gains from Investment Securities high stood at $38.0 million for FY2023, and its period low was $1.5 million during FY2022.
  • Its 3-year average for Gains from Investment Securities is $15.0 million, with a median of $5.5 million in 2024.
  • As far as peak fluctuations go, Vericel's Gains from Investment Securities tumbled by 94.37% in 2021, and later soared by 2,444.24% in 2023.
  • Vericel's Gains from Investment Securities (Yearly) stood at $29.6 million in 2020, then crashed by 94.37% to $1.7 million in 2021, then declined by 10.39% to $1.5 million in 2022, then soared by 2,444.24% to $38.0 million in 2023, then plummeted by 85.61% to $5.5 million in 2024.